Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease

References

• Niu X, Zhu L, Xu Y, Zhang M, Hao Y, Ma L, Li Y, Xing H. Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis. BMC Public Health. 2023;23(1):859. doi:10.1186/s12889-023-15749-x.
   PubMed Web of Science ®Google Scholar
• Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20(1):37–15. doi:10.1038/s41575-022-00688-6.
   PubMed Web of Science ®Google Scholar
• Hartmann P, Zhang X, Loomba R, Schnabl B. Global and national prevalence of nonalcoholic fatty liver disease in adolescents: an analysis of the global burden of disease study 2019. Hepatology. 2023;78(4):1168–1181. doi:10.1097/HEP.0000000000000383.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335–47. doi:10.1097/HEP.0000000000000004.
   PubMed Web of Science ®Google Scholar
• Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VWS, Hartmann P, Thiele M, Caballeria L. et al. Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022;75(1):219–228. doi:10.1002/hep.32163.
   PubMed Web of Science ®Google Scholar
• Jayasekera D, Hartmann P. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease. World J Hepatol. 2023;15(5):609–40. doi:10.4254/wjh.v15.i5.609.
   PubMed Web of Science ®Google Scholar
• Hartmann P, Chu H, Duan Y, Schnabl B. Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either. Am J Physiol Gastrointest Liver Physiol. 2019;316(5):G563–G73. doi:10.1152/ajpgi.00370.2018.
   PubMed Web of Science ®Google Scholar
• Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK. et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 2017;25(5):1054–62.e5. doi:10.1016/j.cmet.2017.04.001.
   PubMed Web of Science ®Google Scholar
• Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, Bettencourt R, Rizo E, Richards L, Xu ZZ. et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat Commun. 2019;10(1):1406. doi:10.1038/s41467-019-09455-9.
   PubMedGoogle Scholar
• Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y. et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017;127(7):2829–41. doi:10.1172/JCI90562.
   PubMed Web of Science ®Google Scholar
• Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, Abraldes JG, Bosques‐Padilla F, Verna EC, Brown RS. et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology. 2020;71(2):522–38. doi:10.1002/hep.30832.
   PubMed Web of Science ®Google Scholar
• Hartmann P, Lang S, Zeng S, Duan Y, Zhang X, Wang Y, Bondareva M, Kruglov A, Fouts, DE, Stärkel P. et al. Dynamic changes of the fungal microbiome in alcohol use disorder. Front Physiol. 2021;12:699253. doi:10.3389/fphys.2021.699253.
   PubMed Web of Science ®Google Scholar
• Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, Bondareva M, Zhang X, Wang Y, Kasper P. et al. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol. 2022;76(4):788–99. doi:10.1016/j.jhep.2021.11.029.
   PubMed Web of Science ®Google Scholar
• Hsu CL, Lang S, Demir M, Fouts DE, Stärkel P, Schnabl B. Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome. Hepatology. 2023;77(6):2073–83. doi:10.1097/HEP.0000000000000238.
   PubMed Web of Science ®Google Scholar
• Maccioni L, Gao B, Leclercq S, Pirlot B, Horsmans Y, De Timary P, Leclercq I, Fouts D, Schnabl B, Stärkel P. et al. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes. 2020;12(1):1782157. doi:10.1080/19490976.2020.1782157.
   PubMed Web of Science ®Google Scholar
• Maccioni L, Horsmans Y, Leclercq I, Schnabl B, Stärkel P. Serum keratin 18-M65 levels detect progressive forms of alcohol-associated liver disease in early noncirrhotic stages. Alcohol (Hanover). 2023;47(6):1079–1087. doi:10.1111/acer.15081.
   Google Scholar
• Naveau S, Lamouri K, Pourcher G, Njiké-Nakseu M, Ferretti S, Courie R, Tranchart H, Ghinoiu M, Balian A, Prévot S. et al. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg. 2014;24(10):1693–701. doi:10.1007/s11695-014-1235-9.
   PubMed Web of Science ®Google Scholar
• Yang X, Chang X, Wu S, Sun X, Zhu X, Wang L, Xu Y, Yao X, Rao S, Hu X. et al. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease. Lipids Health Dis. 2021;20(1):27. doi:10.1186/s12944-021-01453-5.
   PubMed Web of Science ®Google Scholar
• Hartmann P, Schnabl B. New developments in microbiome in alcohol-associated and nonalcoholic fatty liver disease. Semin Liver Dis. 2021;41(1):87–102. doi:10.1055/s-0040-1719174.
   PubMedGoogle Scholar
• Taylor DL, Walters WA, Lennon NJ, Bochicchio J, Krohn A, Caporaso JG, Pennanen T. Accurate estimation of fungal diversity and abundance through improved lineage-specific primers optimized for Illumina Amplicon sequencing. Appl Environ Microb. 2016;82(24):7217–7226. doi:10.1128/AEM.02576-16.
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):3. doi:10.14806/ej.17.1.200.
   Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–8. doi:10.1038/nmeth.2604.
   PubMed Web of Science ®Google Scholar
• Freire M, Moustafa A, Harkins DM, Torralba MG, Zhang Y, Leong P, Saffery R, Bockmann M, Kuelbs C, Hughes T. et al. Longitudinal study of oral microbiome variation in twins. Sci Rep. 2020;10(1):7954. doi:10.1038/s41598-020-64747-1.
   PubMed Web of Science ®Google Scholar
• Singh H, Torralba MG, Moncera KJ, DiLello L, Petrini J, Nelson KE, Pieper R. Gastro-intestinal and oral microbiome signatures associated with healthy aging. Geroscience. 2019;41(6):907–921. doi:10.1007/s11357-019-00098-8.
   PubMed Web of Science ®Google Scholar
• Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microb. 2009;75(23):7537–41. doi:10.1128/AEM.01541-09.
   PubMed Web of Science ®Google Scholar
• Nilsson RH, Larsson KH, Taylor AFS, Bengtsson-Palme J, Jeppesen TS, Schigel D, Kennedy P, Picard K, Glöckner FO, Tedersoo L. et al. The UNITE database for molecular identification of fungi: handling dark taxa and parallel taxonomic classifications. Nucleic Acids Res. 2019;47(D1):D259–D264. doi:10.1093/nar/gky1022.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018. http://www.R-project.org/.
   Google Scholar
• Tang J, Iliev ID, Brown J, Underhill DM, Funari VA. Mycobiome: approaches to analysis of intestinal fungi. J Immunol Methods. 2015;421:112–121. doi:10.1016/j.jim.2015.04.004.
   PubMed Web of Science ®Google Scholar
• Bengtsson-Palme J, Ryberg M, Hartmann M, Branco S, Wang Z, Godhe A, De Wit P, Sánchez‐García M, Ebersberger I, de Sousa F. et al. Improved software detection and extraction of ITS1 and ITS2 from ribosomal ITS sequences of fungi and other eukaryotes for analysis of environmental sequencing data. Methods Ecol Evol. 2013;4(10):914–919. doi:10.1111/2041-210X.12073.
   Web of Science ®Google Scholar
• McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PloS ONE. 2013;8(4):e61217. doi:10.1371/journal.pone.0061217.
   PubMed Web of Science ®Google Scholar
• Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. doi:10.1186/gb-2011-12-6-r60.
   PubMed Web of Science ®Google Scholar
• Cabré N, Hartmann P, Llorente C, Kouno T, Wang Y, Zeng S, Kim HY, Zhang X, Kisseleva T, Iyer S. et al. IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice. Hepatology. 2023;78(1):295–306. doi:10.1097/HEP.0000000000000324.
   PubMed Web of Science ®Google Scholar
• Hartmann P, Lang S, Schierwagen R, Klein S, Praktiknjo M, Trebicka J, Schnabl B. Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure. Hepatobiliary Pancreat Dis Int. 2023;22(5):474–481. doi:10.1016/j.hbpd.2023.05.003.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hartmann P. How to calculate sample size in animal and human studies. Front Med. 2023;10:1215927. doi:10.3389/fmed.2023.1215927.
   Web of Science ®Google Scholar
• Hartmann P, Schnabl B. Risk factors for progression of and treatment options for NAFLD in children. Clin Liver Dis (Hoboken). 2018;11(1):11–5. doi:10.1002/cld.685.
   PubMedGoogle Scholar
• Kaufmann B, Seyfried N, Hartmann D, Hartmann P. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease. Am J Physiol Gastrointest Liver Physiol. 2023;325(1):G42–G61. doi:10.1152/ajpgi.00017.2023.
   PubMed Web of Science ®Google Scholar
• Hartmann P, Schnabl B. Fungal infections and the fungal microbiome in hepatobiliary disorders. J Hepatol. 2023;78:836–851. doi:10.1016/j.jhep.2022.12.006.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63. doi:10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, Singh S, Madamba EV, Bettencourt R, Richards L. et al. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell Metab. 2020;32(5):878–88.e6. doi:10.1016/j.cmet.2020.06.005.
   PubMed Web of Science ®Google Scholar
• Kim SS, Eun JW, Cho HJ, Song DS, Kim CW, Kim YS, Lee SW, Kim Y-K, Yang J, Choi J. et al. Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis. Aliment Pharmacol Ther. 2021;53(4):540–51. doi:10.1111/apt.16200.
   PubMed Web of Science ®Google Scholar
• Lang S, Fairfied B, Gao B, Duan Y, Zhang X, Fouts DE, Schnabl B. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients. Gut Microbes. 2020;12(1):1785251. doi:10.1080/19490976.2020.1785251.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Ponziani FR, Dionisi T, Mosoni C, Vassallo GA, Sestito L, Petito V, Picca A, Marzetti E, Tarli C. et al. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease. Liver Int. 2020;40(4):878–88. doi:10.1111/liv.14383.
   PubMed Web of Science ®Google Scholar
• Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M. et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575(7783):505–11. doi:10.1038/s41586-019-1742-x.
   PubMed Web of Science ®Google Scholar
• Lang S, Schnabl B. Microbiota and fatty liver disease—the known, the unknown, and the future. Cell Host & Microbe. 2020;28(2):233–244. doi:10.1016/j.chom.2020.07.007.
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE, Trauner M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab. 2022;34(11):1700–1718. doi:10.1016/j.cmet.2022.09.017.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. J Hepatol. 2020;72(5):1003–27. doi:10.1016/j.jhep.2020.01.017.
   PubMed Web of Science ®Google Scholar